Skip to content
Archive

KOLINPHARMA® obtains the U.S. patent for Dolatrox®

Dolatrox® is the composition for the treatment of arthropathies and osteoarthritis, as the patent certificate states, for which its innovation and uniqueness have been recognised. For an action aimed at maintaining normal cartilage structure.

“Obtaining our fourth patent, in a country like the United States, a global reference point for scientific research, is a huge source of pride for us,” comments the President, Rita Paola Petrelli.

Research and innovation, with KOLINPHARMA®, always on the side of people’s well-being.

More news

  1. Brevetto USA per Dolatrox®
  2. KOLINPHARMA® prosegue l'operatività aziendale.
  3. KOLINPHARMA® donates a lung ventilator to the city of Catanzaro
Archive